De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience

To determine the clinical fate of patients with de novo deletion 17p13.1 (17p−) chronic lymphocytic leukemia (CLL), we retrospectively studied the outcome of 99 treatment-naive 17p− CLL patients from the M. D. Anderson Cancer Center (n = 64) and the Mayo Clinic (n = 35). Among 67 asymptomatic patien...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood
Egile Nagusiak: Tam, Constantine S., Shanafelt, Tait D., Wierda, William G., Abruzzo, Lynne V., Van Dyke, Daniel L., O'Brien, Susan, Ferrajoli, Alessandra, Lerner, Susan A., Lynn, Alice, Kay, Neil E., Keating, Michael J.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2009
Gaiak:
Clinical Trials and Observations
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4916942/
https://ncbi.nlm.nih.gov/pubmed/19414856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-03-210591
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak